Quality-of-life improvement of the 100 patients treated over the Valvosoft prospective, multi-centre, single-arm first-in-human and pivotal studies: 12 month follow-up.
31 August 2025 (12:30 - 13:15)
Organised by: 
Abstract
About the speaker
European Hospital Georges Pompidou, Paris (France)
9 More presentations in this session
Access the full session
The Event
ESC Congress 2025
31 August 2025
12:30 CET
You may be interested in
Congress Presentation
Congress Session
